Article Text
Statistics from Altmetric.com
The recent BSG guideline on the diagnosis and management of patients at risk of gastric adenocarcinoma1 is a laudable attempt to bring some clarity to this often controversial area. The authors emphasised the importance of high-quality endoscopy with advanced imaging in the management of the patients with gastric atrophy (GA) and gastric intestinal metaplasia (GIM). However, it is still very difficult to relate most of the data presented to the British patient population and the guideline is rather lacking on the place in the pathway of gastric biopsies in establishing the diagnosis of GA or GIM. The guidance clearly focuses on using advanced imaging initially as assessment following an …
Footnotes
Contributors ILPB is the sole contributor to the work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.